LOGIN  |  REGISTER
C4 Therapeutics

Varex Imaging to Participate in Two Investor Conferences

November 17, 2023 | Last Trade: US$14.56 0.26 -1.75

SALT LAKE CITY / Nov 17, 2023 / Business Wire / Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to participate in two upcoming investor conferences.

  • 6th Annual Evercore ISI HealthCONx Conference – November 30, 2023 (Fireside chat & 1x1s)
  • Mizuho Medical Devices & Healthcare Services Summit 2023 – December 6, 2023 (Virtual 1x1s).

More details can be accessed through Varex’s website at www.vareximaging.com/news on the dates listed above.

About Varex

Varex Imaging Corporation is a leading innovator, designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. With a 70+ year history of successful innovation, Varex’s products are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers incorporate Varex’s X-ray sources, digital detectors, connecting devices and imaging software in their systems to detect, diagnose, protect and inspect. Headquartered in Salt Lake City, Utah, Varex employs approximately 2,400 people located in North America, Europe, and Asia. For more information visit vareximaging.com.

Terns Pharmaceuticals

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB